| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation
|
You, Inchul
|
|
|
29 |
11 |
p. 1630-1638.e7
|
artikel
|
| 2 |
Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation
|
Zhu, Xiaotong
|
|
|
29 |
11 |
p. 1616-1629.e12
|
artikel
|
| 3 |
A “light” touch on PI3K to interrogate cancer drug resistance
|
Wang, Tianlu
|
|
|
29 |
11 |
p. 1573-1575
|
artikel
|
| 4 |
Chemoproteomic profiling to identify activity changes and functional inhibitors of DNA-binding proteins
|
Ruprecht, Benjamin
|
|
|
29 |
11 |
p. 1639-1648.e4
|
artikel
|
| 5 |
Ferroptosis inhibition by lysosome-dependent catabolism of extracellular protein
|
Armenta, David A.
|
|
|
29 |
11 |
p. 1588-1600.e7
|
artikel
|
| 6 |
How to kill an ERKsome target: PROTACs deliver the deathblow
|
Potts, Malia B.
|
|
|
29 |
11 |
p. 1569-1571
|
artikel
|
| 7 |
Mechanistic insights into cancer drug resistance through optogenetic PI3K signaling hyperactivation
|
Ueda, Yoshibumi
|
|
|
29 |
11 |
p. 1576-1587.e5
|
artikel
|
| 8 |
Multiplexed bioluminescence imaging with a substrate unmixing platform
|
Brennan, Caroline K.
|
|
|
29 |
11 |
p. 1649-1660.e4
|
artikel
|
| 9 |
PCNA degradation exhibits superior pharmacological effects over stoichiometric inhibition
|
Basu, Ananya A.
|
|
|
29 |
11 |
p. 1571-1573
|
artikel
|
| 10 |
Targeted degradation of PCNA outperforms stoichiometric inhibition to result in programed cell death
|
Chang, Shih Chieh
|
|
|
29 |
11 |
p. 1601-1615.e7
|
artikel
|
Tijdschrift beschrijving